Bioactive compounds: safety and efficacy.
The efficacy and safety of bioactive compounds depend on a few known and unknown parameters. What is a physiologic dose and how can that dose be defined in cases of bioactive compounds with a poor knowledge of supply and distribution? What safety sets are needed? How can individual aspects such as polymorphisms or differences in absorption be considered? A group of experts tried to answer these and related questions during the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart.
Biesalski
Hans-Konrad
HK
Department of Biological Chemistry and Nutrition, University of Hohenheim, Stuttgart, Germany. biesal@uni-hohenheim.de
Dragsted
Lars Ove
LO
Elmadfa
Ibrahim
I
Grossklaus
Rolf
R
Müller
Michael
M
Schrenk
Dieter
D
Walter
Paul
P
Weber
Peter
P
D001688:Biological Products / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D019587:Dietary Supplements; D054796:Drug Dosage Calculations; D006801:Humans; D007408:Intestinal Absorption; D011110:Polymorphism, Genetic
D001688:Biological Products; D015415:Biomarkers